SCHEMBL5651335

SCHEMBL5651335

O=C(O)N(NCc1ccc2c(c1)OCCO2)N1CCCC1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALKBH5 Q6P6C2 1/20 0.48
FTO Q9C0B1 1/20 0.48
ALDH1A1 P00352 6/20 0.46
DPP7 Q9UHL4 1/20 0.44
FAAH O00519 1/20 0.43
TSHR P16473 2/20 0.43
USP2 O75604 1/20 0.43
KDM4E B2RXH2 2/20 0.42
HPGD P15428 5/20 0.42
RECQL P46063 1/20 0.42
CYP2D6 P10635 1/20 0.42
RAB9A P51151 2/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
NPC1 O15118 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5650800 0.99 ALKBH5 (0.47) ALKBH5FTOALDH1A1DPP7FAAH
SCHEMBL5651328 0.82 ALKBH5 (0.48) ALKBH5FTOALDH1A1DPP7FAAH
SCHEMBL9120468 0.73 KDM4E (0.56) ALDH1A1DPP7TSHRKDM4EHPGD
SCHEMBL2937839 0.72 ALDH1A1 (0.65) ALDH1A1HPGDRECQLRAB9AHSD17B10
SCHEMBL3687148 0.72 NPY5R (0.47) ALDH1A1TSHRUSP2KDM4EHPGD
SCHEMBL3689303 0.72 KDM4E (0.49) ALDH1A1FAAHKDM4EHPGDMEN1
SCHEMBL5650660 0.72 ALKBH5 (0.43) ALKBH5FTOALDH1A1DPP7TSHR
SCHEMBL3699466 0.71 ALKBH5 (0.54) ALKBH5FTOALDH1A1DPP7TSHR
SCHEMBL3697550 0.71 KDM4E (0.44) ALDH1A1TSHRKDM4EHPGDCYP2D6
SCHEMBL3687207 0.70 ALKBH5 (0.61) ALKBH5FTOALDH1A1DPP7KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7223776-B2 Compounds with anti-bacterial activity MORPHOCHEM AG (DE) 2007-05-29 US disclosed
US-20060040949-A1 Novel compounds with antibacterial activity MORPHOCHEM AG 2006-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060040949-A1 Novel compounds with antibacterial activity MRPL21, Q6ZSR9, MRPL19 ALKBH5 2802/4885FTO 4747/4885ALDH1A1 2434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.